Exela Pharma Sciences today confirmed the approval of its New drug Application (NDA) and availability of Verapamil HCl Injection, USP 5mg vials (2.5mg/ml). Product is stocked in the major wholesaler distribution channels, and is available in a convenient carton of 5 vials each. This lower pack size of 5 vials coupled with affordable contract pricing available through local Group Purchasing Organizations, leads to significant savings and lower inventory costs for hospitals and healthcare providers. The Verapamil HCl 5mg Injection vials also offer the convenience and safety of a vial versus an ampule. Exela’s Verapamil HCl Injection carries an AP rating
Read More